Therapeutic effects of combining curcumin and swimming in osteoarthritis using a rat model

por Saber, Mona M., Mahmoud, Manal Moustafa, Amin, Hesham M., Essam, Reham M.
Publicado 2023

The ALK inhibitor ASP3026 eradicates NPM-ALK(+) T-cell anaplastic large-cell lymphoma in vitro and in a systemic xenograft lymphoma model

por George, Suraj Konnath, Vishwamitra, Deeksha, Manshouri, Roxsan, Shi, Ping, Amin, Hesham M.
Publicado 2014

SUMOylation Confers Posttranslational Stability on NPM-ALK Oncogenic Protein()

por Vishwamitra, Deeksha, Curry, Choladda V., Shi, Ping, Alkan, Serhan, Amin, Hesham M.
Publicado 2015

A NOX2/Egr-1/Fyn pathway delineates new targets for TKI-resistant malignancies

por Irwin, Mary E., Johnson, Blake P., Manshouri, Roxsan, Amin, Hesham M., Chandra, Joya
Publicado 2015

Type I insulin-like growth factor receptor signaling in hematological malignancies

por Vishwamitra, Deeksha, George, Suraj Konnath, Shi, Ping, Kaseb, Ahmed O., Amin, Hesham M.
Publicado 2016

TrkA is a binding partner of NPM‐ALK that promotes the survival of ALK (+) T‐cell lymphoma

por Shi, Wenyu, George, Suraj Konnath, George, Bhawana, Curry, Choladda V., Murzabdillaeva, Albina, Alkan, Serhan, Amin, Hesham M.
Publicado 2017

The transcription factors Ik-1 and MZF1 downregulate IGF-IR expression in NPM-ALK(+) T-cell lymphoma

por Vishwamitra, Deeksha, Curry, Choladda V, Alkan, Serhan, Song, Yao-Hua, Gallick, Gary E, Kaseb, Ahmed O, Shi, Ping, Amin, Hesham M
Publicado 2015

Inhibition of IGF-IR tyrosine kinase induces apoptosis and cell cycle arrest in imatinib-resistant chronic myeloid leukaemia cells

por Shi, Ping, Chandra, Joya, Sun, Xiaoping, Gergely, Mate, Cortes, Jorge E, Garcia-Manero, Guillermo, Arlinghaus, Ralph B, Lai, Raymond, Amin, Hesham M
Publicado 2010

Targeting Notch1 and proteasome as an effective strategy to suppress T-cell lymphoproliferative neoplasms

por Yang, Lujun, Zhang, Shuangfeng, George, Suraj Konnath, Teng, Rong, You, Xuefen, Xu, Mengqi, Liu, Hong, Sun, Xiaoping, Amin, Hesham M., Shi, Wenyu
Publicado 2015

Correction: Dual inhibition of IGF-IR and ALK as an effective strategy to eradicate NPM-ALK(+) T-cell lymphoma

por George, Bhawana, George, Suraj Konnath, Shi, Wenyu, Haque, Abedul, Shi, Ping, Eskandari, Ghazaleh, Axelson, Magnus, Larsson, Olle, Kaseb, Ahmed O., Amin, Hesham M.
Publicado 2023

Dual inhibition of IGF-IR and ALK as an effective strategy to eradicate NPM-ALK(+) T-cell lymphoma

por George, Bhawana, George, Suraj Konnath, Shi, Wenyu, Haque, Abedul, Shi, Ping, Eskandari, Ghazaleh, Axelson, Magnus, Larsson, Olle, Kaseb, Ahmed O., Amin, Hesham M.
Publicado 2019

SSBP2 is an in vivo tumor suppressor and regulator of LDB1 stability

por Wang, Yang, Klumpp, Sherry, Amin, Hesham M., Liang, Hong, Li, June, Estrov, Zeev, Zweidler-McKay, Patrick, Brandt, Stephen J., Agulnick, Alan, Nagarajan, Lalitha
Publicado 2010

Reversal of Bortezomib Resistance in Myelodysplastic Syndrome Cells by MAPK Inhibitors

por Yue, Yingxing, Wang, Ying, He, Yang, Yang, Shuting, Chen, Zixing, Wang, Yuanyuan, Xing, Shanshan, Shen, Congcong, Amin, Hesham M., Wu, Depei, Song, Yao-Hua
Publicado 2014

RIZ1 is potential CML tumor suppressor that is down-regulated during disease progression

por Lakshmikuttyamma, Ashakumary, Takahashi, Naoto, Pastural, Elodie, Torlakovic, Emina, Amin, Hesham M, Garcia-Manero, Guillermo, Voralia, Michael, Czader, Magdalena, DeCoteau, John F, Geyer, C Ronald
Publicado 2009

DAXX inhibits cancer stemness and epithelial–mesenchymal transition in gastric cancer

por Wu, Chaofan, Ding, Hui, Wang, Shuochen, Li, Yangxin, Liu, Song-Bai, Wang, Xiaoxiao, Zheng, Jiqing, Xue, Ting, Amin, Hesham M., Song, Yao-Hua, Zhou, Jin
Publicado 2020

Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinoma

por Abdel-Wahab, Reham, Shehata, Samir, Hassan, Manal M, Habra, Mouhammed A, Eskandari, Ghazaleh, Tinkey, Peggy T, Mitchell, Jennifer, Lee, Ju-Seog, Amin, Hesham M, Kaseb, Ahmed O
Publicado 2015

Zyxin inhibits the epithelial–mesenchymal transition process in gastric cancer by upregulating SIRT1

por Lou, Jing, Geng, Sha, He, Wei, Liu, Song‐Bai, Shi, Xinghong, Chang, Ying, Han, Shiyuan, Qian, Panting, Amin, Hesham M, Song, Yao‐Hua, Li, Yangxin, Zhou, Jin
Publicado 2023

Origin and role of hepatic myofibroblasts in hepatocellular carcinoma

por Yavuz, Betul Gok, Pestana, Roberto Carmagnani, Abugabal, Yehia I., Krishnan, Sunil, Chen, Jian, Hassan, Manal M., Wolff, Robert A., Rashid, Asif, Amin, Hesham M., Kaseb, Ahmed O.
Publicado 2020

Disruption of Growth Hormone Receptor Signaling Abrogates Hepatocellular Carcinoma Development

por Haque, Abedul, Sahu, Vishal, Lombardo, Jamie Lynne, Xiao, Lianchun, George, Bhawana, Wolff, Robert A, Morris, Jeffrey S, Rashid, Asif, Kopchick, John J, Kaseb, Ahmed O, Amin, Hesham M
Publicado 2022

Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma

por Kaseb, Ahmed Omar, Hassan, Manal, Lacin, Sahin, Abdel-Wahab, Reham, Amin, Hesham M., Shalaby, Ahmed, Wolff, Robert A., Yao, James, Rashid, Asif, Vennapusa, Bharathi, Feng, Janine, Ohtomo, Toshihiko
Publicado 2016